Conference Information

Welcome Message

We are glad to invite you all to the"6^th European Congress on Immunology, Allergy and vaccination" which is going to be held on January 25-26, 2024 in London, UK. Our main aphorism is to gather all the moxie and erected their network connections.

We warmly invite you all to be a part of our conference as speakers, delegates, youthful experimenters, and Attendees to make the conference a successful event. Euro Immunology conference 2024 is all about bringing the talents of the researchers and showcasing their ideas to the Globe.

To break the continuity of immune deficiency disorder, we welcome you to take part to support our society and make a healthy world.

Our conference theme is “To Fight against the immune disorder by vaccination” and aims to bring advanced exploration about immunology, Allergy, and vaccination.

We are confident that Attendees will be enjoyed and get an awful experience.

We hope your presence will make a big success for our conference.

Why attend?

A chance to meet the expertise by attending the conference 6^th European immunology, Allergy and vaccination will gain the knowledge and experience about the recent exploration content.

Attendees will be profitable by getting the benefits like a Certificate from the OCM (Organizing Committee Member) and Abstract publication on Conference supporting journals, Networking openings with global experts.

And there is a network session at the end where you can band your expertise and gather information about the current research and it will be a great occasion to build your network.

Tracks & Sessions

Tracks 1: Mucosal vaccine development

Description Mucosal vaccination can affect systemic as well as mucosal humoral and cell- intermediated vulnerable protection. So, this fashion is used to overcome the entry of pathogens and forestall the need for vaccination. However, entry into mucosal induction spots is enhanced, If the vaccine is in particulate form and adheres to mucosal shells or M- cells, and elicits an ingrain response. From a product and nonsupervisory viewpoint, mucosal vaccines are preferable to systemic vaccines.

Herd immunity
Probiotics
Neisseria

Related Association: The American Association of Immunologists| British Society for Immunology| Indian Immunology Societies| International Union of Immunological Societies| American Academy of Allergy, Asthma & Immunology| European Federation of Immunological Societies| Society for Mucosal Immunology | The American Society for Reproductive Immunology| Clinical Immunology Society| Australasian Society of Clinical Immunology and Allergy

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Track 2: Autoimmune diseases

Conventional autoimmune complaint treatments have centred on astronomically stopping the cycle of inflammation, using impediments of the prostaglandin- cyclooxygenase pathway, or immunosuppressive specifics for a general drop in antibody conformation. For illustration, an illness called lupus can harm the skin, joints, and internal organs.

Diabetes mellitus
Rheumatoid Arthritis
Neuroinflammation
Genome-wide association
Immunodermatology

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 3: Remedy for Asthma

Description Treatment of asthma relies heavily on accurate opinion, complaint genotyping, and monitoring of its inflexibility. Applicable assessment and operation of asthma comorbidities and multimorbidity comorbidities. This includes relations with asthma phenotypes, counteraccusations for perfect drug use, and confirmation of prophetic biomarkers in the field of Immunology.

Biomarkers
Phenotypes and Endotypes
Mental health problems

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Tracks 4: Antigens and antibody

The important session in the vulnerable system is an antigen that's defined by a foreign body entering the body. The antibody is defined as a protein produced in our body to fight against antigens. Your vulnerable system makes a protein called an antibody to target and combat these and fight against these cells.

Stromal signalling
Interferons and Lymphoid Organs
Haematology

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 5: Medicinal Response

It's a form of Toxicology. Adverse drug responses regard 3 to 7 of all hospitalizations in the US. 10 to 20 sanatorium stays are affected by adverse medicine response, and 10 to 20 of these ADRs are severe. The number of ADRs that be to cases who are itinerant and in nursing homes isn't included in these numbers. The field of medicine safety (DS) has a big socioeconomic and public health impact. The field of computer wisdom known as" Knowledge Engineering” (KE) elaborates on strategies and instruments for creating" knowledge- ferocious" systems.

Cancer webbing
Pharmacovigilance
Inheritable Factors
Toxicology

Related Association :The American Association of Immunologists| British Society for Immunology| Indian Immunology Societies| International Union of Immunological Societies| American Academy of Allergy, Asthma & Immunology| European Federation of Immunological Societies| Society for Mucosal Immunology | The American Society for Reproductive Immunology| Clinical Immunology Society| Australasian Society of Clinical Immunology and Allergy

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Tracks 6: Immune Responses

Antigens can enter enterocytes via pinocytosis or relations with nutrient transport systems, or they can pass through the mucosal hedge via paracellular pathways to interact with vulnerable cells. The acuity response has three types known Type 1, type 2, and Type 3. Anaphylaxis and antipathetic rhino conjunctivitis are two exemplifications. We can only be preventative by avoiding the antipathetic substance that can beget the acuity response.

contagious complaint
Respiratory problems

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 7: Food Allergy

Description: Experimental studies point to the possibility that inhaling food allergens may increase food sensitivity and reactions and early-onset AD is linked to a higher risk of allergy sensitization to food allergens in the field of Immunology.

Food antigen sampling
Anaphylaxis
Microbiota
Food microbiology

Related Association :The American Association of Immunologists| British Society for Immunology| Indian Immunology Societies| International Union of Immunological Societies| American Academy of Allergy, Asthma & Immunology| European Federation of Immunological Societies| Society for Mucosal Immunology | The American Society for Reproductive Immunology| Clinical Immunology Society| Australasian Society of Clinical Immunology and Allergy

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Track 8: Immunotherapy

The Immune- checkpoint blocking specifics are successful in a sizable portion of cases that are resistant to conventional remedies. Importantly, recent developments have led to the development of indispensable immunotherapeutic styles that may help to address their downsides. The characteristics of excrescence- associated impunity and immunotherapeutic strategies with colourful molecular mechanisms by showing the typically vulnerable motes whose antibodies are astronomically used in the clinic and those that are still under disquisition.

Cancer immunotherapy

Cellular and molecular immune
Lymphocytes

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 9: Vaccines for COVID- 19

The current exploration content all over the world is COVID. We're still not suitable to get completely cured of the Covid epidemic situation. At the current time, nearly 70 of the population are been vaccinated and it plays an important part in saving people’s lives by improving the Immune system.

Respiratory pattern and SARS
Immunopathology
Cytokine storm

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 10: Vaccines and immunization

Adjuvants, vectors, and high-boost combinations, among others, have the eventuality to significantly impact the creation of coming-generation vaccines. It's used to be boosted by a vaccine to keep a person defended against posterior illness or conditions. substantiation-grounded, informed opinions will be critical for sustaining the success of immunization.

Leukocytes
Immune response
Phagocytosis
Vaccine- convinced vulnerable thrombotic thrombocytopenia

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 11: Paediatrics trials

The Advanced Hospitals around the globe in the field of immunology are two children's hospitals, New York- Presbyterian Morgan Stanley Children's Hospital and New York- Presbyterian Komansky Children's Sanatorium are part of an academic healthcare system that's concertedly powered by New York- Presbyterian, Columbia University, and Weill Cornell Medicine.

Paediatrics healthcare
Neonatology
Women health care
Reproductive Immunology

Related Association :The American Association of Immunologists| British Society for Immunology| Indian Immunology Societies| International Union of Immunological Societies| American Academy of Allergy, Asthma & Immunology| European Federation of Immunological Societies| Society for Mucosal Immunology | The American Society for Reproductive Immunology| Clinical Immunology Society| Australasian Society of Clinical Immunology and Allergy

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Track 12: HIV vaccines for unborn advance

There are no vaccination presently available for mortal immunodeficiency contagion, The need for aggressive antiretroviral remedies in the maturity of HIV- infected people has been demonstrated by a better understanding of HIV pathogenesis. To fully suppress viral replication, at least three medicines must be used in combination. The approach is to develop astronomically negativing antibodies that can grease HIV treatment in numerous ways.

Rear recap
Uncoating system
Antigen stimulation

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 13: Therapists and judgments of Immunology

Multitudinous immunotherapeutic strategies are decreasingly being delved into as indispensable treatments for contagious diseases, leading to major advancements in our understanding of the relations between pathogens and host impunity. new and innovative remedial strategies are the need to overcome a handicap to the contagious complaint.

Adenovirus- vector vaccine
Hereditary angioedema
Immune checkpoint inhibition

Related Association :The American Association of Immunologists| British Society for Immunology| Indian Immunology Societies| International Union of Immunological Societies| American Academy of Allergy, Asthma & Immunology| European Federation of Immunological Societies| Society for Mucosal Immunology | The American Society for Reproductive Immunology| Clinical Immunology Society| Australasian Society of Clinical Immunology and Allergy

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Track 14: Immunohematology

Advancement in immunohematology is ABO typing and involves rapid-fire advancements in individual ways that have made it possible to estimate the antigen-antibody commerce in vitro, greatly perfecting the comity of philanthropist blood with patron blood. Piecemeal from these styles, Rh type, and phenotypic analysis, direct and circular antiglobulin tests, crossmatching, and subsequently antigen and antibody identification is some of the ways used.

Alloimmunization
Non-invasive antenatal testing
X-linked hyperactive- IgM pattern
Hepatitis contagions

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 15: Neuroimmunology

Analogous to its counterpart in the fringe, neuroimmune factors beget their natural goods by interacting with corresponding membrane receptor systems, which also restate the chemical signal by snooping with intracellular signalling pathways. numerous of these intricate signalling mechanisms are still being completely understood. Studies described in the original publication by Erta also used transgenic mice that produce advanced amounts of IL- 6 in the brain through enhanced astrocyte expression.

Chemokine
Neuroinflammation
Transcriptomics
Immune force

Related Association :The American Association of Immunologists| British Society for Immunology| Indian Immunology Societies| International Union of Immunological Societies| American Academy of Allergy, Asthma & Immunology| European Federation of Immunological Societies| Society for Mucosal Immunology | The American Society for Reproductive Immunology| Clinical Immunology Society| Australasian Society of Clinical Immunology and Allergy

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Track 16: Transplantation Immunology

Comity with the major histocompatibility complex of antigens (HLA in humans) is likely to be pivotal in any system for further targeted immunosuppression. Monoclonal antibodies can be used to dampen the vulnerable response at a grainier position by targeting T cell subpopulations or indeed T cells that have been particularly stimulated by the transplant. The discovery that T suppressor cells are responsible for maintaining stable grafts, at least in experimental rodent models, may pave the way for the creation of precise ways for driving the conformation of similar cells in clinical settings.

Keratoplasty
Corneal transplantation
Solid organ transplantation market Analysis

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 17: Insect Immunology

A host's immune response to a pathogen is classified as either innate or adaptive. All creatures, including insects, have the same innate immune response. The nature of the insect immune system has been the subject of prior and contemporary research, and the findings show that the innate immune response of insects is more potent and focused than previously believed. Exposing insects to dead or sublethal doses of microorganisms in order to trigger an early reaction is known as priming of the insect innate immune system. Insect immune responses to repeated infections may have some characteristics with adaptive immune systems, according to research comparing primed insects to unprimed ones. Single-cell transcriptomics may make it possible to identify novel immune cells, measure the cell-to-cell heterogeneity of immune responses, and analyse the diversity of pathogens on a single-cell level. It is expected that a mathematical modelling framework will need to incorporate the multidimensional data sets produced from single-cell transcriptomics in order to describe infection dynamics and make predictions regarding infection outcomes

Melanization
Innate immune system
Invertebrate immunity

Related Association :The American Association of Immunologists| British Society for Immunology| Indian Immunology Societies| International Union of Immunological Societies| American Academy of Allergy, Asthma & Immunology| European Federation of Immunological Societies| Society for Mucosal Immunology | The American Society for Reproductive Immunology| Clinical Immunology Society| Australasian Society of Clinical Immunology and Allergy

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Track 18: Biomedicine in Immunology

Modern immunology research is an exciting and rapidly evolving field of biomedicine.It includes that includes everything from teaching the body how to fight certain diseases to developing antibodies to protect against others. Significant technological advances, combined with a better understanding of the complexities of the immune system and its role in human health and disease, have accelerated efforts to manage and treat diseases like cancer, asthma, and allergies, as well as slow the progression of others like Type 1 diabetes and multiple sclerosis. use of biotechnology techniques to study biological processes and diseases with the ultimate goal of developing effective treatments and cures. Biomedical research is an evolutionary process that necessitates careful experimentation by a diverse group of scientists, including biologists and chemists. The development and evaluation of new medicines and therapies necessitates careful scientific experimentation, development, and evaluation.

Infection and Immunity
Biomedical Neuroscience
Genetic Medicine
Biochemistry

Track 19: Molecular Diagnostics

The development of polymerase chain reaction (PCR), a number of nonPCR techniques, biochips, and nanotechnology, which have sped up the analysis of nucleic acids and proteins, are all included in this discussion of some of the most recent discoveries. Numerous conventional tests have been replaced by molecular diagnostic tests in a number of laboratory medicine specialties, including oncology, infectious diseases, Immunology, clinical chemistry, and clinical genetics. The accuracy and speed with which we can identify microbial pathogens or analyse a patient's genes will continue to improve thanks to developments in molecular diagnostic testing, which is quickly becoming a crucial component of patient-tailored therapeutics and interventions. Clinical laboratories that perform molecular diagnostic tests must constantly adapt to new needs and criteria. For laboratories to be responsive, various alternatives and solutions must be available to meet each customer's requirements. We provide a wide range of instrument platforms, a growing selection of optimised assays, and analysis and reporting software solutions—including IVD solutions and premium components, qualified content and workflows, bioinformatics expertise, and validation services that can help speed up routine analysis of clinical research samples. We also provide these services along with high-quality workflows and qualified content.

Biomarkers
Genomics
Haematology
Molecular Medicine

Related Journal: Expert Review of Vaccines| Vaccine journal| Cellular & Molecular Immunology | Clinical and Experimental Neuroimmunology |Science Immunology

Track 20: Infectious Disease

Society has been burdened with infectious disease outbreaks for centuries, and each time, we learn more. Smallpox tutored us that eradication is possible with wide vaccination and immunity. COVID- 19 showed us the power of viral surveillance in tracking the spread of infection. Coming generation sequencing(NGS) has come an inestimable tool to study and survey arising pathogens that impact public health.

Arising conditions include HIV infections, SARS, Lyme complaint, Escherichia coli O157H7(E. coli), hantavirus, dengue fever, West Nile contagion, and the Zika contagion. Reemerging conditions are conditions that reappear after they've been on a significant decline. The Biden administration's decision to end the covid- 19 public health exigency in May will launch broad changes across the health care system that go far beyond numerous people having to pay further for covid tests.

Sub Tracks:

· Virology

· Emerging and Reemerging Infectious Diseases

· Respiratory infections

· Neurological Disease (Alzheimer's disease)

Related Association :The American Association of Immunologists| British Society for Immunology| Indian Immunology Societies| International Union of Immunological Societies| American Academy of Allergy, Asthma & Immunology| European Federation of Immunological Societies| Society for Mucosal Immunology | The American Society for Reproductive Immunology| Clinical Immunology Society| Australasian Society of Clinical Immunology and Allergy

Related Journal: The Journal of Immunology| Journal of Allergy and Clinical Immunology| Nature Immunology| Journal of Neuroimmunology |Annual Review of Microbiology

Market Analysis

Regional analysis

North America estimated a market analysis of USD 46.17 billion in 2020 and it is predicted that it will increase the global marketing of immunology.
In Europe, during the forecast period, it is estimated as 40,000 people are affected by an autoimmune disease and Rheumatoid arthritis.
In the Asia Pacific, it is the third largest increasing rate of immunology and there is a demand for preventive care, which then continues in the middle east and Africa.

Country analysis:

Vaccination estimated the market analysis to 25$million in 2013 and were exceed to grow 35$million in 2020.
In Europe, it is estimated as there is an increase in the number of vaccination year by year from 2018 to 2025.

The market for cancer immunotherapy was estimated to be worth USD 104.96 billion in 2021 and is anticipated to increase at a CAGR of 7.2% from 2022 to 2030. The primary factors driving the market are an increase in oncology incidence around the world and a spike in R&D efforts for the creation of novel oncology treatments.

Additionally, a number of organisations that fund immunotherapy research exist, which is anticipated to assist market expansion. For instance, to create innovative immune medicines for cancer, the Parker Institute for Cancer Immunotherapy worked with scientists and business pioneers. The United States recorded approximately 2,281,658 cancer cases and 612,390 cancer-related deaths in 2020, according to the Global Cancer Observatory.

It is anticipated that increased financing for the development of innovative therapies will accelerate R&D efforts to create cancer immunotherapy. For instance, the U.S. National Cancer Institute and Cancer Research UK's Cancer Grand Challenges project provided USD 13 million in funding to a team of Stanford scientists in June 2022. The creation of new immunotherapies, research into extrachromosomal DNA, and examination of early-stage cancers are all recipients of this money.

Over the forecast period, it is anticipated that increasing acceptance of innovative immunotherapies will fuel market expansion. The U.S. FDA approved a number of anti-PD-1/L1 antibodies between 2020 and 2022 for the treatment of NSCLC, renal cell carcinoma, melanoma, breast, prostate, and other cancers. These antibodies include nivolumab, atezolizumab, avelumab, dostarlimab, and others.

With a market share of 56.71% in 2021, the hospital pharmacy segment dominated the industry. The demand for immunotherapy in hospitals is on the rise, and the number of hospital admissions is rising as a result of the rise in oncology disorders. Cancer patients were admitted to hospitals at a higher incidence due to the intricacy of their treatments and patients who were over 65. The sector share is therefore high.

The industry segment for online pharmacies is predicted to grow at the fastest rate in the upcoming years. The demand for the online pharmacy segment is projected to be influenced by factors such as the rise in internet usage, rising telemedicine adoption, rising technology adoption, and convenience and time efficiency in the field of Immunology. Additionally, the availability of well-known e-pharmacy players and the deals they provide are crucial.

Checkpoint inhibitors, monoclonal antibodies, interferons, and interleukins are the different categories into which the global market for immunotherapy can be divided. Other immunotherapies, such as vaccinations and hormones, are not covered in this report. The report's scope includes an overview of the global market and analysis of market trends, predicting 2020 through 2025 with compound annual growth rate (CAGR) forecasts using 2019 as the base year.

The paper addresses market-affecting technical, governmental, and economic trends. It also describes the main forces driving the worldwide market, its regional dynamics, and the most recent trends in the sector. The United States and Canada are included in North America, as are the United Kingdom, Germany, France, Spain, Italy, and the rest of Europe, as well as China, India, Japan, and the rest of Asia-Pacific.

Past Conference Report

We unfeignedly thank you all for your continuous support and for being a part of this conference to make a big success.

Our organization has successfully hosted the “5th European Congress on Allergy and Immunology which was held on July 04- 05, 2022 | Webinar” with Great success.

The conference has been full of talented person who was seeking an occasion to present their speech in the field of immunology and Allergy.

We are glad to invite you to the transnational conference on the “6th European congress on immunology, Allergy, and vaccination” which is going to be held on January 25-26, 2024 in London, UK.

We hope for the same response and support for this Immunology conference.

6th European Congress on
Immunology, Allergy and Vaccination

Quick Links

Theme: To Fight against the immune disorder by vaccination

Conference Information

Welcome Message

Tracks & Sessions

Market Analysis

Past Conference Report